Assessing isoproterenol-stimulated whole-body lipolysis in vivo: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
== Assessing Isoproterenol-Stimulated Whole-Body Lipolysis ''in vivo'' ==
 
Background
== Background ==
#Lipolysis is the hydrolysis of triglycerides into glycerol and free fatty acids. Lipolysis is induced through activation of beta adrenergic receptors. Isoproterenol/Isoprenaline is a non-selective beta adrenergic agonist structurally similar to adrenaline. By administering isoproterenol ''in vivo'', it is possible to artificially stimulate whole-body lipolysis and assess changes in the concentrations of the products of lipolysis (i.e., glycerol and free fatty acids) in the blood.
Lipolysis is the hydrolysis of triglycerides into glycerol and free fatty acids. Lipolysis is induced through activation of beta adrenergic receptors. Isoproterenol/Isoprenaline is a non-selective beta adrenergic agonist structurally similar to adrenaline. By administering isoproterenol ''in vivo'', it is possible to artificially stimulate whole-body lipolysis and assess changes in the concentrations of the products of lipolysis (i.e., glycerol and free fatty acids) in the blood.
   
   
Note: Mice do not need to be in a fasted state prior to this test.
Note: Mice do not need to be in a fasted state prior to this test.


Experimental protocol
== Experimental protocol ==
#Briefly anesthetize mice with isofluorane and collect blood via retro orbital bleed. Allow blood to clot over ice.  
#Briefly anesthetize mice with isofluorane and collect blood via retro orbital bleed. Allow blood to clot over ice.  
#Inject 10 mg/kg isoproterenol (prepared fresh in sterile PBS) via intraperitoneal injection.  
#Inject 10 mg/kg isoproterenol (prepared fresh in sterile PBS) via intraperitoneal injection.  
Line 13: Line 13:
#Assay serum for NEFA's and Glycerol/Triglycerides using Wako and Sigma assay kits, respectively.
#Assay serum for NEFA's and Glycerol/Triglycerides using Wako and Sigma assay kits, respectively.


NEFA determination from serum (use Wako Diagnostics NEFA-HR(2) Microtiter Kit)
== NEFA determination from serum (use Wako Diagnostics NEFA-HR(2) Microtiter Kit) ==
#To wells of a clear 96 well plate, add 2.5 uL of water (as blank), appropriate standard (the kit comes with stock of 1 mEq/L. Dilute the stock in ddH20 to give 2.5 and 5 mEq/L standards. For the high standard, add 5 uL of the 1 mEq/L stock. Due to the extra volume, the concentration of this last standard is actually 1.97 mEq/L).
#To wells of a clear 96 well plate, add 2.5 uL of water (as blank), appropriate standard (the kit comes with stock of 1 mEq/L. Dilute the stock in ddH20 to give 2.5 and 5 mEq/L standards. For the high standard, add 5 uL of the 1 mEq/L stock. Due to the extra volume, the concentration of this last standard is actually 1.97 mEq/L).
#To remaining wells, add 2.5 uL of serum samples.
#To remaining wells, add 2.5 uL of serum samples.
Line 25: Line 25:
##Subtract the initial absorbance reading from the final reading, then calculate sample concentrations from the standard curve.
##Subtract the initial absorbance reading from the final reading, then calculate sample concentrations from the standard curve.


Glycerol and Triglyceride determination from serum (use Sigma Diagnostics Triglyceride Assay Kit)
== Glycerol and Triglyceride determination from serum (use Sigma Diagnostics Triglyceride Assay Kit) ==
#To wells of a clear 96 well plate, add 3 uL of water (as blank), the appropriate volume of standard (the kit comes with a stock standard of 2.5 mg/mL triolein; to replicate wells, add 1, 2, 3 and 4 uL of this stock. The assay is only linear up to concentrations of 10 mg/mL, which is 4 uL of 2.5 ug/mL standard).
#To wells of a clear 96 well plate, add 3 uL of water (as blank), the appropriate volume of standard (the kit comes with a stock standard of 2.5 mg/mL triolein; to replicate wells, add 1, 2, 3 and 4 uL of this stock. The assay is only linear up to concentrations of 10 mg/mL, which is 4 uL of 2.5 ug/mL standard).
#To remaining wells, add 3 uL of serum samples.  
#To remaining wells, add 3 uL of serum samples.